Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.5K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

357
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
357
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.

JAMA neurology·2024
Same author

Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementia.

Frontiers in aging neuroscience·2024
Same author

Plasma p-tau immunoassays in clinical research for Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
Same author

Computerized decision support to optimally funnel patients through the diagnostic pathway for dementia.

Alzheimer's research & therapy·2024
Same author

Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
Same author

Increased Disability Progression in rs10191329<sup>AA</sup> Carriers with Multiple Sclerosis Is Preceded by Neurofilament Light Chain Elevations.

Annals of neurology·2024

Related Experiment Video

Updated: Dec 20, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.9K

Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective.

Geert Jan Biessels1, Flavio Nobili2, Charlotte E Teunissen3

  • 1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, Netherlands.

The Lancet. Neurology
|May 24, 2020
PubMed
Summary

Type 2 diabetes increases dementia risk. Research identifies biomarkers for brain changes, potentially guiding future treatments for diabetes-associated cognitive dysfunction.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.2K

Related Experiment Videos

Last Updated: Dec 20, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.0K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.2K

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Type 2 diabetes is linked to higher risks of cognitive impairment, dementia, and Alzheimer's disease.
  • Current guidelines suggest screening for cognitive issues in high-risk diabetic patients.
  • Effective disease-modifying treatments for diabetes-associated cognitive dysfunction are lacking.

Purpose of the Study:

  • To explore the multifactorial mechanisms behind cognitive dysfunction in type 2 diabetes.
  • To highlight the role of novel biomarkers in understanding these mechanisms.
  • To discuss the clinical and research applications of these biomarkers.

Main Methods:

  • Review of recent research integrating findings from dementia, brain aging, diabetes, and vascular disease studies.
  • Identification and analysis of novel biomarkers related to dementia aetiologies, brain injury, and cerebrovascular function.
  • Synthesis of how these biomarkers illuminate underlying pathological processes.

Main Results:

  • Novel biomarkers have been identified for specific dementia types, brain parenchymal injury, and cerebral blood flow/metabolism.
  • These biomarkers offer insights into the processes driving cognitive dysfunction in type 2 diabetes.
  • The identified markers show potential for both research and clinical diagnostic applications.

Conclusions:

  • Understanding the mechanisms of diabetes-associated cognitive dysfunction is crucial due to the lack of targeted treatments.
  • Novel biomarkers are key to elucidating these complex mechanisms.
  • These biomarkers may pave the way for future targeted therapeutic strategies for cognitive decline in type 2 diabetes.